Special Warning : אזהרת שימוש

4.4   Special warnings and precautions for use

As with all injectable vaccines, appropriate medical treatment and supervision should always be available to treat rare cases of anaphylactic reactions following the administration of the vaccine.
Under no circumstances should IXIARO be administered intravascularly.

As with any other vaccine, vaccination with IXIARO may not result in protection in all cases. IXIARO will not protect against encephalitis caused by other micro- organisms.
Like other intramuscular injections, this vaccine should not be administered intramuscularly to persons with thrombocytopenia, haemophilia or other bleeding disorders (see section 4.2).
In adults a seroconversion rate of 29.4 % has been observed 10 days after the first vaccination, and 97.3 % one week after the second i.m. vaccination in the conventional schedule. After immunisation with the rapid schedule a seroconversion rate of 99% has been observed 7 days after the second i.m.
vaccination. Hence, primary immunization should be completed at least one week prior to potential exposure to Japanese encephalitis virus (JEV).
Protection against Japanese Encephalitis is not ensured until the second dose has been received.

Effects on Driving

4.7   Effects on ability to drive and use machines

IXIARO has no or negligible influence on the ability to drive and use machines.